Company Statement on COVID-19
Exelixis is actively monitoring the global COVID-19 pandemic, and remains steadfast in our commitment to the health and safety of our patients, customers, employees and local communities.
Tackling Difficult-to-Treat Cancers
To date, we have three medicines available to treat certain types of kidney, liver and thyroid cancers and advanced melanoma.
At Exelixis, everyone leads in our collective quest to drive for results so patients can have hope for remission.